Oruka Therapeutics, Inc. · NASDAQ:ORKA

Quinlan Paul T sold 9,000 Oruka Therapeutics, Inc. shares (Form 4)

Traded Oct 20, 2026 · Filed Oct 20, 2026

On Oct 20, 2026, Quinlan Paul T (General Counsel) sold 9,000 Oruka Therapeutics, Inc. shares at an average US$78.53 for US$707K under a trading plan, leaving 29,995 shares. Filed Oct 20, 2026 (Form 4).

Sold: 9,000 shares
Price: US$78.53 average (US$74.90 to US$79.49)
Value: US$707K
Holding after: 29,995 shares
Trading plan: Yes (Made under a plan set in advance)
Role: General Counsel

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 20, 2026	Common Stock	Option exercise	9,000	US$7.80	38,995	Direct
Oct 20, 2026	Common Stock	Sale	400	US$74.90	38,595	Direct
Oct 20, 2026	Common Stock	Sale	500	US$76.12	38,095	Direct
Oct 20, 2026	Common Stock	Sale	1,000	US$77.21	37,095	Direct
Oct 20, 2026	Common Stock	Sale	4,100	US$78.79	32,995	Direct
Oct 20, 2026	Common Stock	Sale	3,000	US$79.49	29,995	Direct

Source

Download original · View original at SEC

Related